4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001628280-26-074541
Chief Executive Officer returned 660,830.84 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Frank D. Chief Executive Officer | 2026-11-17 | Returned to the company | −660,830.84 | $36.50 | $24,120,326 | 0 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lee Frank D. Chief Executive Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −692,512 | $32.07 | 2034-01-03 | 692,512 | 0 | D: show line 2 in the form |
Loading xslF345X06/wk-form4_1794951433.xml…